Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
oral drug delivery
Pharma
Novo Nordisk applies for FDA approval of semaglutide obesity pill
Novo Nordisk has submitted for FDA approval of an oral version of Wegovy. It would be the world’s first oral GLP-1 obesity treatment.
Kevin Dunleavy
Apr 22, 2025 8:50am
Viking taps CordenPharma in $150M obesity drug production deal
Mar 11, 2025 10:25am
Lilly starts banking stockpile of oral GLP-1 asset
Feb 24, 2025 10:47am
Roche picks up FDA nod for easier Evrysdi dosing format in SMA
Feb 12, 2025 2:30pm
Lyndra enlists Thermo Fisher for research, manufacturing support
Jan 15, 2025 3:36pm
Alpha Cognition's Alzheimer's drug passes muster with FDA
Jul 29, 2024 9:34am
.jpg?VersionId=q4GwTDTSG74TowmgwTM7k8SOdrX6o.bX)
